Allen Wolstenholme

Statistics

Publications

Citations

178

H-Index

Active since

2017

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Allen Wolstenholme is an author at GlaxoSmithKline (United States) specializing in pharmacology, clinical pharmacology, and relative oral bioavailability.

Publications per year

2017–2019

Publications

Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of <scp>RIPK</scp>1 inhibitor <scp>GSK</scp>2982772 in healthy volunteers

Kathleen Weisel, Nicola Scott, Debra Tompson et al. · Pharmacology Research & Perspectives · 2017 · 130 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Effect of Sorbitol on the Pharmacokinetic Profile of Lamivudine Oral Solution in Adults: An Open‐Label, Randomized Study

Kimberly K. Adkison, Allen Wolstenholme, Yu Lou et al. · Clinical Pharmacology & Therapeutics · 2017 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers

J.-P. Llanos Ackert, Khadeeja Mohamed, Jason S. Slakter et al. · Drug Safety · 2019 · 12 citations · Full text

Medicine, Ophthalmology, Pharmacology +16

1–3 of 3